Clinical trial

Pemefolacianine for IMI of Lung Cancer

NCT07772895

Study summary

ClinicalTrials.gov

Pemefolacianine for IMI of Lung Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE1

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Pemefolacianine Cohort 1 in Part A Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Pemefolacianin Cohort 2 in Part B Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2026-03-11

PhasePHASE1

Conditions

Lung Cancer (Locally Advanced or Metastatic)unresolved

Interventions

Pemefolacianine Cohort 1 in Part ADRUG

Pemefolacianin Cohort 2 in Part BDRUG

Sponsors & collaborators

Sunil Singhallead sponsor

Mapped research locations

PhiladelphiaPennsylvania, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07772895 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.